Aducanumab FDA Approval for Alzheimer's Disease: The Importance of G…

Anton Porsteinsson

Differentiating Early Signs of Alzheimer Disease From Normal Signs o…

ACHL

J. Galvin

Lewy Body Dementia: The Most Common Disease You Never Heard Of

University of Miami

J. Galvin

Embracing Aging: Helping Our Loved Ones, Helping Ourselves

Pacific Neuroscience Institute

S. Kaiser, A. Effinger

Cognitive Disorders

ZINCARE

M. Mataa

Approach to Cognitive Impairment in Adults

ZINCARE

M. Mataa

Gut Microbiome and the Brain

BRAIN PONDERINGS podcast with Mark Mattson

J. Cryan

Early Diagnosis of Alzheimer’s Disease

Sharon Cohen

Aducanumab: What Neurologists Should Know - Clinical Impact, Indicat…

Northwestern Medicine Neurology and Neurosurgery

I. Grant

Neuropsychological Assessment in Dementia Diagnosis

Northwestern Medicine Neurology and Neurosurgery

S. Weintraub

AAIC 2024 Insights: Effects of Gut Microbiota Dysbiosis on Cognitive…

AAIC 2024 Insights Hub

Y. (Laura) Zhang

Updates in Dementia

2023 Conference Coverage

P. Tipton

Preventing Cognitive Decline with Lithium

Psychiatry Redefined

J. Greenblatt

Lewy Body Dementia: The Most Common Disease You Never Heard Of - 2024

AdventHealth

J. Galvin

Alzheimer's: Clinical Pearls

Lawrence Robbins

New & Emerging Treatments in Alzheimer's Disease

University of Miami

E. Crocco

An Update on Alzheimer's Disease: New Strategies Across the Disease …

Miller Medical Communications

P. Tariot

AAIC 2024 Insights: Potential of Targeting the Alpha-1 Adrenergic Re…

AAIC 2024 Insights Hub

S. G. Pattanashetty

The Illusion of Progress: Lecanemab in Alzheimer's Disease

Alberto Espay

A New Era for Brain Health in Primary Care: New Drugs and Diagnostics

University of Kansas Medical Center

J. M. Burns